Market Entry & Commercialisation Consulting
Independent, structured advisory for manufacturers evaluating or planning entry into a new market, before you commit resources to a launch.
Four pieces of clarity before you commit
Market sizing and opportunity assessment
A grounded read on demand, addressable segments, and realistic near-term volume, sized against comparable categories already active in the market.
Regulatory pathway mapping
The specific approval route for your product class, the evidence and documentation required, realistic timelines, and where local clinical data may be needed.
Competitive and pricing intelligence
Who else is active in the category, how they're priced and positioned across channels, and where a new entrant has room to compete.
Go-to-market strategy design
A channel and sequencing plan: which segments, geographies, and account types to prioritise first, and what a credible launch actually requires.
Best suited to manufacturers who want to decide before they build
Typically engaged by manufacturers with no current presence in the target market, or teams evaluating whether an existing product line extends into new therapy areas or export geographies.
Independent
You retain full decision-making control; the engagement is advisory, not operational.
Time-boxed
Structured as a defined engagement with a clear deliverable, not an open-ended retainer.
A natural first step
Many principals move into an End-to-End Partnership once the opportunity is validated.